Aquestive Therapeutics, Inc. Common Stock AQST
$3.79
+2.57%
at last close
Market Cap$475.52 million
P/E Ratio—
Div Yield—
Volume2.38M
52-Week Range
$2.93$7.55
Key Stats
- Today's Range
- $3.67 – $3.82
- 50-Day Range
- $3.56 – $5.18
- 52-Week Range
- $2.93 – $7.55
- Volume
- 2.38 million shs
- Average Volume
- 2.23 million shs
- Market Cap
- $475.52 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- -13.96
- Price / Sales
- 9.46
Short Interest
- Short Interest
- 0.00%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- $50.27 million
- Net Income
- $-68,911,000
- Net Margin
- -137.08%
- Return on Equity
- 202.36%
- Debt-to-Equity
- -1.32
About Aquestive Therapeutics, Inc. Common Stock
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.